Potential for cytologic breast fluid analysis in breast disease

1986 ◽  
Vol 8 (1) ◽  
pp. 21-23 ◽  
Author(s):  
Shahnaz Hashmi Dairkee ◽  
Adeline J. Hackett
Cancer ◽  
1985 ◽  
Vol 56 (6) ◽  
pp. 1473-1478 ◽  
Author(s):  
Ernst L. Wynder ◽  
Heli Lahti ◽  
Kristiina Laakso ◽  
Shu-Lin Cheng ◽  
Susan Debevoise ◽  
...  

The Breast ◽  
2007 ◽  
Vol 16 (5) ◽  
pp. 489-494 ◽  
Author(s):  
Edward R. Sauter ◽  
Patricia A. Ganz ◽  
Hormoz Ehya ◽  
John E. Hewett ◽  
Lisa Schlatter ◽  
...  

1977 ◽  
Vol 59 (4) ◽  
pp. 1073-1080 ◽  
Author(s):  
Otto W. Sartorius ◽  
Helene S. Smith ◽  
Peter Morris ◽  
Doris Benedict ◽  
Lawrence Friesen
Keyword(s):  

Author(s):  
Nicholas L. Petrakis

SynopsisThe breast of the nonpregnant woman secretes, retains or reabsorbs a variety of endogenous and exogenous biochemical substances of potential physiological and clinical significance. Among these substances are steroid hormones, prolactin, growth hormones, and peptide growth factors. Because the concentrations of these hormones secreted into the breast ducts are often significantly higher than the concentrations in serum, the breast epithelium is commonly exposed to very high concentrations of steroid and other hormones which may play a role in the aetiology and pathogenesis of breast disease.This paper presents a brief review of published data on the cytological and biochemical constituents of breast fluid obtained by nipple aspiration and data on factors affecting oestradiol and oestrone concentrations in breast fluid. Concentrations of oestradiol and oestrone in nipple aspirate fluid are much higher than in serum, not correlated with serum levels, much lower in women who recently have given birth or breast-fed their infants, not related to day in menstrual cycle, and higher in women with biopsied benign breast disease compared with nulliparous women without breast disease.Further studies of the interrelationships of hormones, other biochemical constituents and the cytopathology of breast fluid may provide new insights into the pathophysiology and aetiology of breast diseases.


Author(s):  
R.P. Apkarian ◽  
J.S. Sanfilippo

The synthetic androgen danazol, is an isoxazol derivative of ethisterone. It is utilized in the treatment of endometriosis, fibrocystic breast disease, and has a potential use as a contraceptive. A study was designed to evaluate the ultrastructural changes associated with danazol therapy in a rat model. The preliminary investigation of the distal segment of the rat uterine horn was undertaken as part of a larger study intended to elucidate the effects of danazol on the female reproductive tract.Cross-sections (2-3 mm in length) of the distal segment of the uterine horn from sixteen Sprague-Dawley rats were prepared for SEM. Ten rats in estrus served as controls and six danazol treated rats were noted to have alterations of the estrus cycle i.e. a lag in cycle phase or noncycling patterns. Specimens were fixed in 3% glutaraldehyde in 0.05M phosphate buffer containing CaCl2 at pH 7.0-7.4 and chilled to 4°C. After a brief wash in distilled water, specimens were passed through a graded series of ethanol, critical point dryed in CO2 from absolute ethanol, and coated with 6nm Au. Observations were made with an IS1-40 SEM operated at 15kV.


Sign in / Sign up

Export Citation Format

Share Document